VivoSim Labs VIVS
NASDAQ VIVS
$0.28 0.00 (-0.11%)
As of: Aug 21, 2026 · 12:17 PM EDT

VivoSim Labs (VIVS) EPS (Basic) (2011 - 2026)

VivoSim Labs (VIVS) posted quarterly EPS (Basic) of -$1.22 for Q1 2026, up 32.29% year-over-year from -$0.92 in Q1 2025, and down 10.19% quarter-over-quarter from -$1.11 in Q4 2025.

VivoSim Labs (VIVS) EPS (Basic) (2011 - 2026) Analysis & Trends

VivoSim Labs' EPS (Basic) history runs 16 years deep, the most recent figure standing at -$1.22 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 32.29% year-over-year to -$1.22; the TTM figure through Mar 2026 stood at -$4.52 (up 46.76% YoY), while the FY2026 annual figure was -$5.49, up 47.4% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$1.22, down from -$1.11 in the prior quarter.
  • The five-year high for EPS (Basic) was -$1.03 in Q3 2025, with the low at -$10.27 in Q1 2023.
  • The 5-year median for EPS (Basic) is -$2.89 (2022), against an average of -$3.56.
  • The sharpest annual moves came in 2023 and 2024: EPS (Basic) plunged 255.58% in 2023, then jumped 67.81% in 2024.
  • VivoSim Labs' EPS (Basic) stood at -$4.51 in 2022, then dropped by 8.84% to -$4.91 in 2023, then soared by 51.66% to -$2.37 in 2024, then jumped by 53.39% to -$1.11 in 2025, then decreased by 10.19% to -$1.22 in 2026.
  • Business Quant data shows VIVS's EPS (Basic) at -$1.22 in Q1 2026, -$1.11 in Q4 2025, and -$1.03 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.82 Bn 131.97 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 86.70 Bn 78.71 Bn 3.93 Bn 12.62
3 Argenx Se 65.27 Bn 60.09 Bn 1.37 Bn 7.59
4 Moderna 59.18 Bn 54.04 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.11 Bn 37.01 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn 1.23
7 BioNTech SE 28.14 Bn 9.75 Bn 668.28 Mn -0.72
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.26 Bn 26.42 Bn - 0.18
10 VivoSim Labs 1.45 Mn 1.45 Mn - -0.52

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.18
Mar 31, 2026 -1.22
Dec 31, 2025 -1.11
Sep 30, 2025 -1.03
Jun 30, 2025 -1.19
Mar 31, 2025 -1.80
Dec 31, 2024 -2.37
Sep 30, 2024 -1.83
Jun 30, 2024 -2.84
Mar 31, 2024 -3.70
Dec 31, 2023 -4.91
Sep 30, 2023 -5.67
Jun 30, 2023 -5.74
Mar 31, 2023 -10.27
Dec 31, 2022 -4.51
Sep 30, 2022 -4.79
Jun 30, 2022 -4.59
Mar 31, 2022 -2.89
Dec 31, 2021 -5.55
Sep 30, 2021 -4.83